+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
All Genders
Healthy Volunteers
ID07171281

Impact of Early versus Late Time-Restricted Eating with Caloric Reduction on Glycemic Control and Cardiometabolic Health in Overweight Adults with Prediabetes and Type 2 Diabetes The GLYCOTIME Trial

Led by German Institute of Human Nutrition · Updated on 2026-09-29

30

Participants Needed

1

Research Sites

8 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are examining how limiting eating to specific 8-hour windows earlier or later in the day, combined with moderate calorie reduction, affects glucose metabolism and heart-related health factors in overweight adults. The study includes people with normal glucose levels, prediabetes, or type 2 diabetes not treated with insulin. It also aims to understand the molecular changes linked to these eating patterns. Participants follow two different dietary schedules in a crossover design one where they eat mostly in the morning early time-restricted eating and another where they eat mostly in the evening late time-restricted eating. Each eating phase lasts five weeks with a 10- to 12-week break between them. During both phases, participants reduce daily calories by 25%, replacing one meal with a lower-calorie product, with the timing personalized to their natural body clock. Throughout the study, participants undergo various assessments including continuous glucose monitoring, blood tests for insulin and cholesterol, body measurements, gene expression analysis from fat and blood cells, and surveys about hunger, sleep quality, and quality of life. The main measure is the average 24-hour glucose level during each 5-week phase. The total study duration, including both eating phases and the washout period, extends over several months, allowing detailed evaluation of the dietary interventions effects.

CONDITIONS

Brief Title

Precise Eating Time to Improve Glycemic Control and Cardiometabolic Health in Prediabetes and Diabetes

Research Team

O

Olga Ramich, Prof. Dr.

B

Bettina Schuppelius, M.Sc.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here